Application of Human Papillomavirus in Screening for Cervical Cancer and Precancerous Lesions |
Wang, Jin-Liang
(Department of General Oncology, Chinese PLA General Hospital)
Yang, Yi-Zhuo (Department of Obstetrics and Gynecology, Chinese PLA General Hospital) Dong, Wei-Wei (Department of General Oncology, Chinese PLA General Hospital) Sun, Jing (Department of Obstetrics and Gynecology, Chinese PLA General Hospital) Tao, Hai-Tao (Department of General Oncology, Chinese PLA General Hospital) Li, Rui-Xin (Department of General Oncology, Chinese PLA General Hospital) Hu, Yi (Department of General Oncology, Chinese PLA General Hospital) |
1 | Balbi G, Napolitano A, Giordano F, et al (2012). Role of the association of high-risk HPV identified by real-time PCR in cervical preneoplastic lesions. Eur J Gynaecol Oncol, 33, 467-71. |
2 | Berois N, De Cremoux P, Mazal D, et al (2013). Prevalence and distribution of high-risk human papillomavirus genotypes in invasive carcinoma of the uterine cervix in Uruguay. Int J Gynecol Cancer, 23, 527-32. DOI ScienceOn |
3 | Bolgova LS, Tuganova TN, Alekseenko OI (2012). The cytological diagnostics of dysplasia and epidermoid carcinoma of the cervix in studying the nucleolar-organizing regions of chromosomes. Klin Lab Diagn, 11, 36-41. |
4 | Canadian Task Force on Preventive Health Care, Pollock S, Dunfield L, et al (2013). Recommendations on screening for cervical cancer. CMAJ, 185, 35-45. DOI |
5 | Corcoran J, Dattalo P, Crowley M (2012). Cervical cancer screening interventions for U.S. Latinas: a systematic review. Health Soc Work, 37, 197-205. DOI |
6 | Croswell J, Costello A (2012). Screening for cervical cancer. Am Fam Physician, 86, 563-4. |
7 | Ding L, Zou XJ, Ao JE, et al (2008). ELISA test to detect CDKN2A (p16(INK4a)) expression in exfoliative cells: a new screening tool for cervical cancer. Mol Diagn Ther, 12, 395-400. DOI ScienceOn |
8 | Dollin J (2013). Preventing cervical cancer: beyond following guidelines. CMAJ, 185, 13-4. DOI |
9 | Galarowicz B, Jach R, Kidzierska J, et al (2012). The role of mRNA E6/E7 HPV high oncogenic risk expression in colposcopy of cervical intraepithelial neoplasia (CIN). Przegl Lek, 69, 651-7. |
10 | Gerli S, Bavetta F, Di Renzo GC (2012). Antisepsis regimen in the surgical treatment of HPV generated cervical lesions: polyhexamethylene biguanide vs chlorhexidine. A randomized, double blind study. Eur Rev Med Pharmacol Sci, 16, 1994-8. |
11 | Giraldi G, De Luca d'Alessandro E (2012). The HPV infection in males: an update. Ann Ig, 24, 497-506. |
12 | Jablonowska D, Marszalek A, Bodnar M (2012). Tabacco smoking, HPV infection and changes in cervix. Przegl Lek, 69, 740-3. |
13 | Jach R, Posadzka E, Sliwińska A, et al (2012). The influence of surgery of cervical intraepithelial neoplasia (CIN) and cervical carcinoma on quality of life. Przegl Lek, 69, 647-50. |
14 | Konno R (2013). Screening of uterine cervical neoplasms and HPV vaccine. Gan To Kagaku Ryoho, 40, 165-9. |
15 | Li J, Kang LN, Qiao YL (2011). Review of the cervical cancer disease burden in mainland China. Asian Pac J Cancer Prev, 12, 1149-53. |
16 | Li RF, Gupta M, McCluggage WG, et al (2013). Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: report of a case series and review of the literature. Am J Surg Pathol, 37, 344-55. DOI |
17 | Pruski D, Fraszczak J, Iwaniec K, et al (2012). Assessment of frequency of regression and progression of mild cervical neoplasia-LGSIL in women with positive high-risk HPV DNA test result. Ginekol Pol, 83, 572-5. |
18 | McCann GA, Boutsicaris CE, Preston MM, et al (2013). Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease. Gynecol Oncol, 129, 135-9. DOI ScienceOn |
19 | Ohta Y, Kunimura T, Omatsu M, et al (2013). Mixed mucinproducing and squamous differentiated tumor of the uterine cervix: a report of a case as adenosquamous carcinoma in situ. J Obstet Gynaecol Res, 39, 420-3. DOI ScienceOn |
20 | Piura E, Piura B (2012). Brain metastases from cervical carcinoma: overview of pertinent literature. Eur J Gynaecol Oncol, 33, 567-73. |
21 | Rai B, Patel FD, Chakraborty S, et al (2013). Bladder-rectum spacer balloon in high-dose-rate brachytherapy in cervix carcinoma. Int J Radiat Oncol Biol Phys, 85, e217-22. DOI ScienceOn |
22 | Salehi M, Taheri T, Mohit E, et al (2012). Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model. Immunotherapy, 4, 1107-20. DOI ScienceOn |
23 | Singhal P, Hussain S, Thakur N, et al (2013). Association of MDM2 and p53 polymorphisms with the advancement of cervical carcinoma. DNA Cell Biol, 32, 19-27. DOI ScienceOn |
24 | Xue Y, An R, Zhang D, et al (2011). Detection of survivin expression in cervical cancer cells using molecular beacon imaging: new strategy for the diagnosis of cervical cancer. Eur J Obstet Gynecol Reprod Biol, 159, 204-8. DOI ScienceOn |
25 | Zeng XT, Xiong PA, Wang F, et al (2012). Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls. Asian Pac J Cancer Prev, 13, 2687-93. DOI ScienceOn |
26 | Zhao FH, Tiggelaar SM, Hu SY, et al (2012). A multi-center survey of HPV knowledge and attitudes toward HPV vaccination among women, government officials, and medical personnel in China. Asian Pac J Cancer Prev, 13, 2369-78. DOI ScienceOn |
![]() |